Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Gout
Related studies linked through entity extraction aliases.
Single and Multiple Dose Study in Japanese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Purine Metabolism Enzyme SNP to Uric Acid Production
- Status
- COMPLETED
- Phase
- N/A
The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
- Status
- UNKNOWN
- Phase
- N/A
Lesinurad and Febuxostat Combination Extension Study in Gout
- Status
- COMPLETED
- Phase
- PHASE3
Lesinurad and Allopurinol Combination Extension Study in Gout
- Status
- COMPLETED
- Phase
- PHASE3
Allopurinol in Acute Gout
- Status
- WITHDRAWN
- Phase
- NA
Single and Multiple Dose Study in Japanese
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout
- Status
- COMPLETED
- Phase
- PHASE3
The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
- Status
- TERMINATED
- Phase
- NA
Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)
- Status
- COMPLETED
- Phase
- N/A
Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
- Status
- COMPLETED
- Phase
- PHASE4
Open-Label Lesinurad Monotherapy Extension Study in Gout
- Status
- COMPLETED
- Phase
- PHASE3
Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
- Status
- UNKNOWN
- Phase
- N/A
Meta-analyses of Total and Individual Fructose-containing Sugars and Incident Cardiometabolic Disease
- Status
- UNKNOWN
- Phase
- N/A
Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life
- Status
- COMPLETED
- Phase
- N/A
Postmarketing Study to Determine Performance of the SIGMA HP® PARTIAL KNEE SYSTEM
- Status
- COMPLETED
- Phase
- PHASE4
Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout
- Status
- UNKNOWN
- Phase
- PHASE2
Combining Lesinurad With Allopurinol in Inadequate Responders
- Status
- COMPLETED
- Phase
- PHASE3